Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: a randomized, controlled, open phase IIb study. - von Minckwitz,G.; Costa,S.D.; Raab,G.; Blohmer,J.U.; Eidtmann,H.; Hilfrich,J.; Merkle,E.; Jackisch,C.; Gademann,G.; Tulusan,A.H.; Eiermann,W.; Graf,E.; et al. (J Clin Oncol, 2001)